OmerHassanJamyMD

PubMed

• Addition of single dose gemtuzumab ozogamicin to intensive induction chemotherapy in core-binding factor acute myeloid leukemia.
  Garrett Bourne, Kendall Diebold, Manuel Espinoza-Gutarra, Zaid Al-Kadhimi, Kimo Bachiashvili, Sravanti Rangaraju, Pankit Vachhani, Ravi Bhatia, Omer Jamy> ;Leukemia Research. 2024 Apr 1
• Radiation-free conditioning in acute lymphoblastic leukemia: is it time?
  Espinoza-Gutarra, M., Mohty, R., Jamy, O.> ;Chinese Clinical Oncology. 2024 Feb 4
• Allogeneic hematopoietic cell transplantation for blastic plasmacytoid dendritic cell neoplasm: a CIBMTR analysis.
  Abid, M. B., Hemant S Murthy, Mei-Jie Zhang, Karen Chen, Sairah Ahmed, Uday Deotare, Siddhartha Ganguly, Ankit Kansagra, Fotios V Michelis, Taiga Nishihori, Mrinal Pat...> ;Blood Advances. 2023 Nov 28
• Integrating electronic geriatric assessment and frailty screening for adults with acute myeloid leukemia to drive personalized treatment decisions.
  Omer Hassan Jamy, Margaret Kasner, Sarah Wall, Stacey Ingram, D 'Ambra Dent, William N Dudley, Leah Dudley, Julie M Scott, Debra Wujcik> ;Leukemia Research. 2023 Nov 1
• Utility of end of induction bone marrow biopsy and survival outcomes in acute promyelocytic leukemia treated with fixed-dose induction regimen.
  Sydney Dunn-Valadez, Srilakshmi Bathini, Kathleen E Purdy, Kimo Bachiashvili, Ravi Bhatia, Omer Jamy, Sravanti Rangaraju, Amitkumar Mehta, Kelly Godby, Gaurav Goyal, S...> ;Leukemia & Lymphoma. 2023 Oct 1
• 3 citations
  Novel developments in the prophylaxis and treatment of acute GVHD.
  Omer Jamy, Robert Zeiser, Yi-Bin Chen> ;Blood. 2023 Sep 21
• 46 citations
  Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis.
  Javier Bolaños-Meade, Mehdi Hamadani, Juan Wu, Monzr M Al Malki, Michael J Martens, Lyndsey Runaas, Hany Elmariah, Andrew R Rezvani, Mahasweta Gooptu, Karilyn T Larkin...> ;The New England Journal of Medicine. 2023 Jun 22
• 1 citations
  Goals, preferences, and concerns of patients with acute myeloid leukemia at time of treatment decision.
  Omer Hassan Jamy, William N Dudley, Leah S Dudley, Julie M Scott, Debra Wujcik> ;Journal of Geriatric Oncology. 2023 Jul 1
• 4 citations
  The COVID-19 Pandemic and In-Person Visit Rate Disruptions Among Patients With Hematologic Neoplasms in the US in 2020 to 2021.
  Gaurav Goyal, Krystal W Lau, Xiaoliang Wang, Amy J Davidoff, Scott F Huntington, Omer Jamy, Gregory Calip, Harsh Shah, Deborah M Stephens, Rebecca Miksad, Ravi B Parik...> ;JAMA Network Open. 2023 Jun 1
• Impact of induction intensity and transplantation on outcomes of patients with complex karyotype and TP53-mutated acute myeloid leukemia.
  Omer Jamy, Kendall Diebold, Kenneth Davis, Kimo Bachiashvili, Sravanti Rangaraju, Pankit Vachhani, Kelly N Godby, Donna Salzman, Ravi Bhatia> ;Bone Marrow Transplantation. 2023 Jul 1
• Correction to: Impact of pre-transplant induction and consolidation cycles on AML allogeneic transplant outcomes: a CIBMTR analysis in 3113AML patients.
  Michael Boyiadzis, Mei-Jie Zhang, Karen Chen, Hisham Abdel-Azim, Muhammad Bilal Abid, Mahmoud Aljurf, Ulrike Bacher, Talha Badar, Sherif M Badawy, Minoo Battiwalla, Ne...> ;Leukemia. 2023 May 1
• 9 citations
  Association between the choice of the conditioning regimen and outcomes of allogeneic hematopoietic cell transplantation for myelofibrosis.
  Guru Subramanian Guru Murthy, Soyoung Kim, Noel Estrada-Merly, Muhammad Bilal Abid, Mahmoud Aljurf, Amer Assal, Talha Badar, Sherif M Badawy, Karen Ballen, Amer Beitin...> ;Haematologica. 2023 Jul 1
• Immune reconstitution profile after allogeneic hematopoietic stem cell transplantation with post-transplant cyclophosphamide.
  Manuel Espinoza-Gutarra, Ayman Saad, Omer Jamy> ;Stem Cell Investigation. 2023 Jan 1
• Impact of pre-transplant individual comorbidities on risk of ICU admission and survival outcomes following allogeneic hematopoietic stem cell transplantation.
  Omer Jamy, John Dasher, Alice Chen, Donna Salzman, Ravi Bhatia, Bhatia, S.> ;Bone Marrow Transplantation. 2023 Mar 1
• 3 citations
  Impact of pre-transplant induction and consolidation cycles on AML allogeneic transplant outcomes: a CIBMTR analysis in 3113 AML patients.
  Michael Boyiadzis, Mei-Jie Zhang, Karen Chen, Hisham Abdel-Azim, Muhammad Bilal Abid, Mahmoud Aljurf, Ulrike Bacher, Talha Badar, Sherif M Badawy, Minoo Battiwalla, Ne...> ;Leukemia. 2023 May 1
• 9 citations
  Adaptation of Remote Symptom Monitoring Using Electronic Patient-Reported Outcomes for Implementation in Real-World Settings.
  Gabrielle B Rocque, D'Ambra N Dent, Stacey A Ingram, Nicole E Caston, Haley B Thigpen, Fallon R Lalor, Omer H Jamy, Smith Giri, Andres Azuero, Jennifer Young Pierce, C...> ;JCO Oncology Practice. 2022 Dec 1
• 3 citations
  Dismal survival outcomes of patients with acute myeloid leukemia after failure of venetoclax with hypomethylating agents.
  Carl Zainaldin, Sankalp Arora, Srilakshmi Bathini, Udita Gupta, Vishruti Pandya, Sejong Bae, Sarah Worth, Kimo Bachiashvili, Ravi Bhatia, Kelly Godby, Omer Jamy, Srava...> ;Leukemia & Lymphoma. 2022 Dec 1
• 1 citations
  Hypomethylating agent/venetoclax versus intensive chemotherapy in adults with relapsed or refractory acute myeloid leukaemia.
  Omer Jamy, Karen Lin, Sarah Worth, Kimo Bachiashvili, Sravanti Rangaraju, Pankit Vachhani, Ravi Bhatia> ;British Journal of Haematology. 2022 Aug 1
• Phase II study of myeloablative allogeneic hematopoietic stem cell transplantation for acute lymphoblastic leukemia in adults using fludarabine and total body irradiat...
  Omer Jamy, Sankalp Arora, Ruby Meredith, Donna Salzman, Antonio Di Stasi, Kentaro Minagawa, Shin Mineishi, Ayman Saad> ;Bone Marrow Transplantation. 2022 Oct 1
• 5 citations
  Tumor lysis syndrome and infectious complications during treatment with venetoclax combined with azacitidine or decitabine in patients with acute myeloid leukemia.
  Sankalp Arora, Carl Zainaldin, Srilakshmi Bathini, Udita Gupta, Sarah Worth, Kimo Bachiashvili, Ravi Bhatia, Kelly Godby, Omer Jamy, Sravanti Rangaraju, Barry Diamond,...> ;Leukemia Research. 2022 Jun 1
• 7 citations
  Risk of Cytomegalovirus Infection with Post-Transplantation Cyclophosphamide in Haploidentical and HLA-Matched Unrelated Donor Transplantation.
  Omer Jamy, Courtney Hebert, Sydney Dunn-Valadez, Tylan Magnusson, Nicole Watts, Gerald McGwin, Ayman Saad> ;Transplantation and Cellular Therapy. 2022 Apr 1
• 1 citations
  Safe and Effective Use of Imatinib to Treat Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia During Pregnancy.
  Sarah Ashraf, Julie Wolfson, Pankit Vachhani, Sravanti Rangaraju, Kimo Bachiashvili, Ravi Bhatia, Omer Jamy> ;Journal of Adolescent and Young Adult Oncology. 2022 Dec 1
• 4 citations
  Risk of mortality and second malignancies in primary myelofibrosis before and after ruxolitinib approval.
  Omer Jamy, Mithun Vinod Shah, Pankit Vachhani, Ronald S Go, Gaurav Goyal, Thomas, J.> ;Leukemia Research. 2022 Jan 1
• 2 citations
  First report of novel heterozygous WRAP53 p.Ala522Glyfs*8 mutation associated dyskeratosis congenita.
  Tylan Magnusson, Richard Curtis Godby, Kimo Bachiashvili, Omer Jamy> ;British Journal of Haematology. 2021 Oct 14
• 6 citations
  Impact of sociodemographic factors on early mortality in acute promyelocytic leukemia in the United States: A time-trend analysis.
  Omer Jamy, Aditi Dhir, Luciano J. Costa, Ana C. Xavier> ;Cancer. 2021 Sep 8
• Join now to see all

Abstracts/Posters

• Genomic Landscape of Sex Disparities in Multiple Myeloma
  Omer Jamy, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Lectures

• A phase II study of myeloablative allogeneic hematopoietic stem cell transplantation (aHSCT) for acute lymphoblastic leukemia (ALL) in older patients using fludarabine... 
  ASCO Annual Meeting 2019 - Chicago, IL - 6/3/2019
• A Phase II Clinical Trial of Post-Transplant Cyclophosphamide for Graft Versus Host Disease Prevention Following Myeloablative Peripheral Blood Stem Cell Matched Unrel... 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019